Emergex Vaccines Raises US$11 million to further execution of the COVID-19 vaccine development

Professional
Investments
- Corporate Finance
- EIS / SEIS Opportunities
Pensions
- SIPPs
- SSAS
- Life Insurance
- ISAs
About us
News
Contact
Payment Form

Emergex Vaccines Raises US$11 Million to Advance Pipeline of Synthetic T-Cell Vaccines for Infectious Diseases

This is a press release with a link attached here.

Sign up for our newsletter

Keep up to date with all the latest news from Wilton.

LONDON | ISLE OF MAN | IRELAND | DUBAI | BRISTOL | BLACKBURN

London +44 (0)20 7355 3525 | IOM +44 (0)1624 675610 | Ireland +353 (0)1 405 4882 | Dubai +971 (0)4 441 0518 | Bristol +44 (0)117 316 9991 | Blackburn +44 (0)125 466 0333info@wiltongroup.com

Privacy Policy | Terms & Conditions | Covid-19 Update and Secure Risk Assessment

© 2020 The Wilton, Website design by bob

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking privacy preferences.

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. Because we respect your right to privacy, you can choose not to allow some types of services, however not allowing some services may impact your experience and the services we are able to offer.

Google Maps

We use the Google Maps plugin in order to show you the locations of our offices.

Tracking

We use Google Analytics to collect information to monitor visitor numbers and engagement with certain pages of content within the site.

Open toolbar

Accessibility Tools

Increase Text
Decrease Text
Grayscale
High Contrast
Negative Contrast
Light Background
Links Underline
Readable Font
Reset